Clinical trials
Completed Colonic Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 5 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 6 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 9 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 76 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 13 |
| NCIC Clinical Trials Group | 7 |
| National Cancer Institute (NCI) | 7 |
| Amgen | 4 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 4 |
| Novartis Pharmaceuticals | 3 |
| Ottawa Hospital Research Institute | 3 |
| University Health Network, Toronto | 3 |
| University of British Columbia | 3 |
| AHS Cancer Control Alberta | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colonic Neoplasms | 76 |
| Colorectal Neoplasms | 41 |
| Rectal Neoplasms | 40 |
| Neoplasms | 9 |
| Breast Neoplasms | 8 |
| Neoplasm Metastasis | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Lung Neoplasms | 6 |
| Inflammatory Bowel Diseases | 5 |
| Colonic Polyps | 4 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.